Skip to search.
 FTSE 100 Up 3.08%

BIND Therapeutics, Inc. (BIND)

-NasdaqGS
1.36 Up 0.02(1.12%) 12 Feb 21:00
Prev Close:1.35
Open:1.39
Bid:N/A
Ask:1.89 x 400
1y Target Est:8.67
Beta:N/A
Earnings Date:9 Mar - 14 Mar (Est.)
Day's Range:1.29 - 1.43
52wk Range:1.14 - 8.10
Volume:50,820
Avg Vol (3m):110,321
Market Cap:28.27m
P/E (ttm):N/A
EPS (ttm):-1.95
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for BIND at this time.

Comparison

Symbol% ChgMkt Cap
BINDUp 1.12%28.27m
PGNXDown 1.47%279.92m
BMYUp 1.14%100.43b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.98
Quarterly EPS Est (Dec-15) :-0.49
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company, develops various targeted and programmable therapeutics. It is developing Accurins that are designed with specific pharmaceutical characteristics intended to target tumors at... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback